| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product compounding quality issue | FAERS: 3 | US FAERS | |
| 2 | Alopecia | FAERS: 2 | US FAERS | |
| 3 | Ammonia increased | FAERS: 2 | US FAERS | |
| 4 | Drug ineffective | FAERS: 2 | US FAERS | |
| 5 | Drug level below therapeutic | FAERS: 2 | US FAERS | |
| 6 | Product quality issue | FAERS: 2 | US FAERS | |
| 7 | Asthenia | FAERS: 1 | US FAERS | |
| 8 | Drug level decreased | FAERS: 1 | US FAERS | |
| 9 | Dry skin | FAERS: 1 | US FAERS | |
| 10 | Fatigue | FAERS: 1 | US FAERS | |
| 11 | Mental status changes | FAERS: 1 | US FAERS | |
| 12 | Onychoclasis | FAERS: 1 | US FAERS | |
| 13 | Pallor | FAERS: 1 | US FAERS | |
| 14 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 15 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 16 | Swelling | FAERS: 1 | US FAERS | |
| 17 | Vomiting | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.